12 January 2023
Join us for the Linesight Life Sciences Benchmarking Webinar.
At our public webinar on Tuesday the 24th January, our panel of experts will provide an overview of the benchmarking programme and provide high-level insights that have emerged from analysis of over 168 global projects valued at US$26 billion.
Initiated in 2020, the Linesight Capital Project Benchmarking programme is a global collaboration of leading pharmaceutical companies, to benchmark and align cost and schedule data across capital projects. It has gained significant traction in the market, with seventeen of the world’s leading pharmaceutical companies* currently collaborating in the programme.
To register and learn more about the webinar, please click here.